Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gastritis, Atrophic | 2 | 2018 | 20 | 1.41 | Why? |
| Gastrointestinal Agents | 3 | 2018 | 393 | 1.14 | Why? |
| Spleen | 4 | 2021 | 877 | 1.07 | Why? |
| Multimorbidity | 3 | 2018 | 703 | 1.05 | Why? |
| Celiac Disease | 2 | 2019 | 471 | 0.92 | Why? |
| Transglutaminases | 2 | 2019 | 77 | 0.91 | Why? |
| Splenic Diseases | 1 | 2021 | 28 | 0.90 | Why? |
| Internal Medicine | 4 | 2021 | 557 | 0.90 | Why? |
| Duodenum | 2 | 2019 | 179 | 0.88 | Why? |
| GTP-Binding Proteins | 2 | 2019 | 132 | 0.88 | Why? |
| Crohn Disease | 3 | 2020 | 959 | 0.80 | Why? |
| Lymphocyte Depletion | 1 | 2020 | 293 | 0.75 | Why? |
| Intestinal Diseases | 2 | 2019 | 231 | 0.75 | Why? |
| Abortion, Habitual | 1 | 2018 | 35 | 0.72 | Why? |
| Medication Adherence | 2 | 2018 | 1270 | 0.70 | Why? |
| Liver Failure | 1 | 2020 | 266 | 0.66 | Why? |
| Adalimumab | 1 | 2020 | 389 | 0.63 | Why? |
| Infertility, Female | 1 | 2018 | 150 | 0.61 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2020 | 669 | 0.61 | Why? |
| Helicobacter pylori | 1 | 2016 | 262 | 0.52 | Why? |
| Inflammatory Bowel Diseases | 6 | 2021 | 3209 | 0.51 | Why? |
| Autoantibodies | 3 | 2019 | 2094 | 0.49 | Why? |
| Biopsy | 3 | 2019 | 2811 | 0.48 | Why? |
| Virion | 1 | 2020 | 1444 | 0.46 | Why? |
| Colitis, Ulcerative | 3 | 2018 | 1037 | 0.44 | Why? |
| Frailty | 2 | 2018 | 1432 | 0.40 | Why? |
| Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.39 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.36 | Why? |
| Gastritis | 2 | 2017 | 66 | 0.34 | Why? |
| Autoimmune Diseases | 2 | 2018 | 1996 | 0.33 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.31 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.30 | Why? |
| Aging | 2 | 2018 | 3581 | 0.29 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.26 | Why? |
| Remission Induction | 2 | 2018 | 950 | 0.26 | Why? |
| Nurses | 1 | 2019 | 2285 | 0.26 | Why? |
| Gastrointestinal Tract | 2 | 2021 | 1113 | 0.22 | Why? |
| Peptic Ulcer Hemorrhage | 1 | 2020 | 24 | 0.21 | Why? |
| Stomach | 1 | 2021 | 141 | 0.21 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.21 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.21 | Why? |
| Erythrocyte Count | 1 | 2021 | 137 | 0.21 | Why? |
| Upper Gastrointestinal Tract | 1 | 2020 | 61 | 0.21 | Why? |
| Stomach Ulcer | 1 | 2020 | 101 | 0.20 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.20 | Why? |
| Physicians | 1 | 2019 | 4214 | 0.20 | Why? |
| Peptic Ulcer | 1 | 2020 | 85 | 0.20 | Why? |
| Biological Therapy | 2 | 2021 | 456 | 0.19 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.19 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.19 | Why? |
| Italy | 12 | 2020 | 38444 | 0.19 | Why? |
| Chromogranin A | 1 | 2018 | 15 | 0.19 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.19 | Why? |
| Chimera | 1 | 2018 | 83 | 0.19 | Why? |
| Myofibroblasts | 1 | 2018 | 61 | 0.19 | Why? |
| Pouchitis | 1 | 2018 | 20 | 0.18 | Why? |
| Internship and Residency | 1 | 2019 | 4987 | 0.18 | Why? |
| Anemia, Iron-Deficiency | 1 | 2021 | 210 | 0.18 | Why? |
| Biological Factors | 1 | 2021 | 276 | 0.17 | Why? |
| Heart Conduction System | 1 | 2020 | 266 | 0.17 | Why? |
| Extracellular Matrix | 1 | 2018 | 189 | 0.17 | Why? |
| Gastrointestinal Diseases | 4 | 2021 | 2580 | 0.17 | Why? |
| Serotonin | 1 | 2018 | 137 | 0.17 | Why? |
| Splenectomy | 1 | 2017 | 85 | 0.17 | Why? |
| Vitamin B 12 | 1 | 2018 | 132 | 0.16 | Why? |
| Atrophy | 1 | 2016 | 192 | 0.16 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.16 | Why? |
| Enteritis | 1 | 2017 | 147 | 0.16 | Why? |
| Gastrointestinal Microbiome | 2 | 2021 | 1961 | 0.15 | Why? |
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 129 | 0.15 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.15 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.14 | Why? |
| Hemoglobins | 1 | 2021 | 958 | 0.14 | Why? |
| Humans | 36 | 2021 | 930598 | 0.14 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.14 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.14 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.14 | Why? |
| Adult | 16 | 2021 | 244371 | 0.14 | Why? |
| Helicobacter Infections | 1 | 2016 | 216 | 0.13 | Why? |
| Patient Acuity | 2 | 2020 | 1755 | 0.13 | Why? |
| Child Behavior | 1 | 2017 | 266 | 0.13 | Why? |
| Drug Costs | 1 | 2017 | 313 | 0.13 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.12 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.12 | Why? |
| Endoscopy, Gastrointestinal | 2 | 2020 | 1545 | 0.12 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.12 | Why? |
| Venous Thromboembolism | 2 | 2020 | 4273 | 0.12 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.12 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Heart Rate | 1 | 2020 | 1527 | 0.11 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.11 | Why? |
| Adolescent Behavior | 1 | 2017 | 400 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.11 | Why? |
| Male | 19 | 2021 | 367725 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Patient-Centered Care | 1 | 2018 | 860 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.10 | Why? |
| Aged | 14 | 2021 | 215776 | 0.10 | Why? |
| Endoscopy | 2 | 2017 | 1564 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.10 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.10 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Biomarkers | 4 | 2020 | 23361 | 0.09 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Vaccination Coverage | 1 | 2017 | 1249 | 0.09 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.08 | Why? |
| Hospitalization | 5 | 2020 | 54280 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Liver | 1 | 2020 | 4007 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Liver Diseases | 2 | 2021 | 2698 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Serologic Tests | 1 | 2019 | 4359 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.07 | Why? |
| Registries | 3 | 2018 | 12327 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Primary Health Care | 1 | 2021 | 4839 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Blood Gas Monitoring, Transcutaneous | 1 | 2021 | 52 | 0.06 | Why? |
| Cholinesterases | 1 | 2021 | 48 | 0.06 | Why? |
| Enteric Nervous System | 1 | 2021 | 28 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.05 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Colonic Pouches | 1 | 2018 | 17 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Action Potentials | 1 | 2020 | 368 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2021 | 508 | 0.05 | Why? |
| Pancreatic Diseases | 1 | 2021 | 191 | 0.04 | Why? |
| Proctocolectomy, Restorative | 1 | 2018 | 51 | 0.04 | Why? |
| Colitis | 1 | 2021 | 266 | 0.04 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Ileum | 1 | 2018 | 233 | 0.04 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Dysbiosis | 1 | 2021 | 685 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Infliximab | 1 | 2018 | 502 | 0.03 | Why? |
| Anemia | 1 | 2021 | 789 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2018 | 469 | 0.03 | Why? |
| Steroids | 1 | 2017 | 904 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.03 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Trust | 1 | 2014 | 1487 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Health Services Needs and Demand | 1 | 2014 | 3419 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |